Blood biomarkers like p-tau217 are emerging as a way to detect Alzheimer's disease. The first FDA-approved blood-based ...
Alzheimer’s disease biomarkers measured from finger-prick dried blood samples closely match standard plasma tests and predict ...
New potential for Alzheimer disease biomarker testing found in dried blood collection derived from capillary blood.
FDA approves first venous stent for IVC and iliofemoral veins, offering a new treatment for deep venous disease with proven 12-month patency.
Patients with retinal vascular occlusion had an elevated risk for Alzheimer’s disease and related dementias, new research shows.
This population-based study shows that shared and pattern-specific blood biomarkers reflect biological vulnerability ...
Because the risk of many conditions increases with age, doctors generally recommend more frequent lab testing as you get ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback